Published in J Alzheimers Dis on January 01, 2010
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
The meaning of translational research and why it matters. JAMA (2008) 20.37
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Central challenges facing the national clinical research enterprise. JAMA (2003) 17.41
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet (2008) 8.51
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med (2003) 7.83
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
2008 Alzheimer's disease facts and figures. Alzheimers Dement (2008) 4.33
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci (2005) 2.36
An anatomic gene expression atlas of the adult mouse brain. Nat Neurosci (2009) 2.30
Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron (2002) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25
Dementia in the elderly: the silent epidemic. Ann Intern Med (1982) 2.24
Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry (2001) 2.04
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain (2007) 1.99
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther (2008) 1.86
Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment. Neuropsychology (2009) 1.85
What's next in translational medicine? Clin Sci (Lond) (2007) 1.85
Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics. J Am Geriatr Soc (2001) 1.82
Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proc Natl Acad Sci U S A (2009) 1.66
Neuroprotective effects of curcumin. Adv Exp Med Biol (2007) 1.59
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol (2007) 1.55
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry (2008) 1.51
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology (2006) 1.47
Drug discovery: new models for industry-academic partnerships. Drug Discov Today (2008) 1.45
Neuropsychiatric aspects of progressive supranuclear palsy. Neurology (1996) 1.41
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol (2001) 1.37
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology (2009) 1.34
C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity. Proc Natl Acad Sci U S A (2008) 1.32
Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J Am Chem Soc (2009) 1.30
Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models. Neuropsychopharmacology (2005) 1.28
Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia (2007) 1.26
A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron (2006) 1.23
Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22
Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology (2009) 1.20
Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol (2009) 1.12
Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry (2005) 1.11
Frontotemporal dementia: therapeutic interventions. Front Neurol Neurosci (2009) 1.10
Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10
Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry (2007) 1.08
Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol (1996) 1.08
Selective inhibition of Abeta42 production by NSAID R-enantiomers. J Neurochem (2002) 1.07
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry (2006) 1.07
Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol (1998) 1.04
Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry (2006) 1.02
Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases. J Cereb Blood Flow Metab (1984) 1.01
Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J Alzheimers Dis (2009) 1.01
Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 1.00
Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer Dis Assoc Disord (1987) 0.99
Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci (2007) 0.99
Cognitive function and prediction of dementia in old age. Int J Aging Hum Dev (1987) 0.98
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. Am J Psychiatry (2004) 0.98
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Curr Pharm Des (2008) 0.97
Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Ann Neurol (2001) 0.97
Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. Am J Alzheimers Dis Other Demen (2006) 0.96
Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol (2005) 0.94
Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord (2001) 0.94
Drug discovery through industry-academic partnerships. Nat Chem Biol (2006) 0.90
The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and application. J Clin Exp Neuropsychol (2009) 0.87
Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study. Am J Geriatr Pharmacother (2005) 0.87
Imaging cerebral microvascular amyloid. Ann Neurol (2007) 0.82
Aging and semantic cueing during learning and retention of verbal episodic information. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 0.82
Memory prediction accuracy in younger and older adults: a cross-sectional and longitudinal analysis. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 0.81
Clinical differences among types of dementia. Ann Neurol (1984) 0.79
NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders. Neuropsychopharmacology (2008) 0.78
Dementia: clinical application of positron emission tomography. Am J Physiol Imaging (1988) 0.76
Positron computed tomography. JAMA (1982) 0.76
Effects of age and divided attention on memory components derived for the category exemplar generation task. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2007) 0.75
The Frontal Systems Behavior Scale in the evaluation of dementia. Int J Geriatr Psychiatry (2008) 0.75
Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2005) 1.88
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis (2013) 1.05
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2012) 1.02
Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography. J Magn Reson Imaging (2013) 0.94
Younger age of dementia diagnosis in a Hispanic population in southern California. Int J Geriatr Psychiatry (2014) 0.82
Family history of dementia in early-onset versus very late-onset Alzheimer's disease. Int J Geriatr Psychiatry (2006) 0.78